Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

• Haiyan Xu,

  Affiliation Department of Cardiology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, P. R. China

  ⨯
• Bingjian Wang,

  Affiliation Department of Cardiology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, P. R. China

  ⨯
• Jing Yang,

  Affiliation Department of Cardiology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, P. R. China

  ⨯
• Shuren Ma,

  Affiliation Department of Cardiology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, P. R. China

  ⨯
• Xiongwei Xie

  * E-mail: xie_xiongwei@163.com

  Affiliation Department of Cardiology, Huai’an First People’s Hospital, Nanjing Medical University, Huai’an, Jiangsu, P. R. China

  http://orcid.org/0000-0001-5333-0423

  ⨯